Add BrightSurf on Google Email

New experimental drug may restore movement after stroke

Researchers discovered that strokes cause a chain reaction within the brain, leading to neuronal cell death. They found that blocking collagen production can prevent this damage and even restore motor function in paralyzed monkeys. The new drug KDS12025 reduces hydrogen peroxide levels and prevents the entire process from being triggered.

SourceInstitute for Basic Science·JournalCell Metabolism·TypeExperimental study·DateApr 27, 2026

Oxygen therapy subsides abnormal movements in a rare childhood disease

Researchers discovered that administering oxygen during episodes of dystonia significantly reduces symptoms and improves quality of life. The study found that rapid oxygen delivery interrupts cortical spreading depression, a phenomenon linked to hypoxia and triggering the condition.

SourceInstitut du Cerveau (Paris Brain Institute)·JournalMovement Disorders·TypeCase study·DateFeb 20, 2023

Feasibility study of novel core-strengthening intervention shows promise for maximizing trunk and balance rehabilitation outcomes after stroke

Researchers tested a core-strengthening program using the AllCore360º to improve trunk function, balance, and mobility after stroke. The study showed promising effects on functional outcomes, including improved lateral control of posture and standardized treatment dosage.

SourceKessler Foundation·JournalBrain Sciences·TypeExperimental study·DateAug 12, 2022
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

For stroke survivors, modified cardiac rehabilitation can reduce the chances of death by 76%

A modified cardiac rehabilitation program has been shown to reduce mortality rates among stroke survivors by 76%. The program, which includes medically supervised exercise and therapy, improves functional capacity, mobility, self-care, and cognition. This finding has the potential to change the future of stroke care.

SourceElsevier·JournalJournal of Stroke and Cerebrovascular Diseases·TypeObservational study·DateMay 3, 2022

Robot-assisted therapy can help treat stroke survivors, study finds

Researchers at UTHealth found that exoskeleton-assisted rehabilitation can be beneficial for stroke survivors, correcting impaired walking patterns and increasing motor coordination. The study used the Ekso 1.1 exoskeleton to guide patients with chronic post-stroke hemiplegia or hemiparesis in a 10-15 session training program over thre...

SourceUniversity of Texas Health Science Center at Houston·JournalJournal of Neural Engineering·DateAug 30, 2021

High-dose gait training with robotic exoskeleton may improve function after acute stroke

Researchers found that high-dose gait training using a robotic exoskeleton can restore functional ambulation in individuals with moderate to severe hemiplegia caused by stroke. The study showed improvements in walking distance, speed, balance, and endurance, with no complications or falls reported.

SourceKessler Foundation·JournalNeuroRehabilitation An International Interdisciplinary Journal·TypeExperimental study·DateAug 3, 2021
GQ GMC-500Plus Geiger Counter

GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.

Stroke and sensory rehabilitation research

Researchers investigate auditory brainstem responses for early detection of ototoxic hearing loss, as well as sensory rehabilitation methods such as obstacle avoidance training, blind rehabilitation, and constraint-induced therapy. These studies aim to minimize or prevent debilitating hearing loss and improve mobility function in indiv...

SourceVeterans Affairs Research Communications·JournalThe Journal of Rehabilitation Research and Development·DateJul 8, 2004

Early promise for stroke patients given levodopa and physiotherapy

A preliminary study suggests that levodopa combined with physiotherapy can improve motor recovery in stroke patients. After three weeks of treatment, the levodopa group showed a significant improvement in motor function compared to the placebo group, with an RMA score gain of 6.4 points versus 4.1 points.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 6, 2001